SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (18261)1/28/1999 5:39:00 PM
From: Curt Whitaker  Respond to of 23519
 
What does concern me is that they cut R&D spending... Now I want to know WHAT was cut...

Did any money come out of the Gene Therapy program? What was said about it in the cc?

I had a damn meeting and missed the cc....

Curt



To: VLAD who wrote (18261)1/28/1999 5:46:00 PM
From: betty moyers  Respond to of 23519
 
Vlad, Warehousing product ahead of time does not effect revenue. If the scripts are equal or higher in Q1 than Q4 then revenue will be equal or higher

What was said about the domestic partnership? I was unable to be there for the conference call.

Were there any forward looking statements at all?



To: VLAD who wrote (18261)1/28/1999 5:49:00 PM
From: Andreas Samson  Read Replies (1) | Respond to of 23519
 
You're talking about FALSE PROFITS, Vlad.

I know it's not what you want to hear right now, but a return to profitability by cost-cutting alone, in the face of substantial NEGATIVE TOP-LINE GROWTH, has dubious validity.

Did I mis-hear things or did Wilson just pre-announce no int'l shipments (i.e., losses) Q1 and Q2?

That's not gonna send the stock to $6.